BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37573725)

  • 1. CD34 immunostain increases the sensitivity of placental examination for distal fetal vascular malperfusion in liveborn infants.
    Stanek J
    Placenta; 2023 Sep; 140():117-124. PubMed ID: 37573725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental recent/on-going foetal vascular malperfusion with endothelial fragmentation is diagnostically equivalent to established distal villous lesions of foetal vascular malperfusion.
    Stanek J
    Pol J Pathol; 2022; 73(3):198-207. PubMed ID: 36734434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distal villous lesions are clinically more relevant than proximal large muscular vessel lesions of placental fetal vascular malperfusion.
    Stanek J
    Histol Histopathol; 2022 Apr; 37(4):365-372. PubMed ID: 34939657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental CD34 immunohistochemistry in fetal vascular malperfusion in stillbirth.
    Stanek J; Drach A
    J Obstet Gynaecol Res; 2022 Mar; 48(3):719-728. PubMed ID: 35092332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of the Large Fetal Vessel Lesions in Placental Fetal Vascular Malperfusion.
    Stanek J
    Lab Invest; 2024 May; 104(7):102089. PubMed ID: 38810837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34 immunostain increases the sensitivity of placental diagnosis of fetal vascular malperfusion in stillbirth.
    Stanek J; Abdaljaleel M
    Placenta; 2019 Feb; 77():30-38. PubMed ID: 30827353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34 immunostain increases sensitivity of the diagnosis of fetal vascular malperfusion in placentas from ex-utero intrapartum treatment.
    Stanek J
    J Perinat Med; 2021 Feb; 49(2):203-208. PubMed ID: 32903209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal heterogeneity of placental segmental fetal vascular malperfusion: timing but not etiopathogenesis.
    Stanek J
    Virchows Arch; 2021 May; 478(5):905-914. PubMed ID: 32918597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental fetal vascular malperfusion in congenital diaphragmatic hernia.
    Stanek J
    Virchows Arch; 2024 Jan; 484(1):83-91. PubMed ID: 37439836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single Umbilical Artery Umbilical Cord Is Associated With High-Grade Distal Fetal Vascular Malperfusion.
    Stanek J
    Pediatr Dev Pathol; 2024; 27(1):52-58. PubMed ID: 37771135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Placenta in Neonatal Encephalopathy: A Case-Control Study.
    Vik T; Redline R; Nelson KB; Bjellmo S; Vogt C; Ng P; Strand KM; Nu TNT; Oskoui M
    J Pediatr; 2018 Nov; 202():77-85.e3. PubMed ID: 30369428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of placental injury in various types of fetal congenital heart disease.
    Stanek J
    J Perinat Med; 2023 Jun; 51(5):704-711. PubMed ID: 36573345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal vascular malperfusion (FVM): diagnostic implications and clinical associations.
    Ravikumar G; Mascarenhas D; Suman Rao PN; Crasta J
    J Matern Fetal Neonatal Med; 2022 Dec; 35(23):4526-4533. PubMed ID: 33261528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segmental villous mineralization: A placental feature of fetal vascular malperfusion.
    Stanek J
    Placenta; 2019 Oct; 86():20-27. PubMed ID: 31358342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Umbilical cord compromise versus other clinical conditions predisposing to placental fetal vascular malperfusion.
    Stanek J
    Placenta; 2022 Sep; 127():8-11. PubMed ID: 35921763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal and fetal vascular lesions of malperfusion in the placentas associated with fetal and neonatal death: results of a prospective observational study.
    Kulkarni VG; Sunilkumar KB; Nagaraj TS; Uddin Z; Ahmed I; Hwang K; Goudar SS; Guruprasad G; Saleem S; Tikmani SS; Dhaded SM; Yogeshkumar S; Somannavar MS; McClure EM; Goldenberg RL
    Am J Obstet Gynecol; 2021 Dec; 225(6):660.e1-660.e12. PubMed ID: 34111407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental delayed villous maturation is associated with fetal congenital heart disease.
    O'Hare CB; Mangin-Heimos KS; Gu H; Edmunds M; Bebbington M; Lee CK; He M; Ortinau CM
    Am J Obstet Gynecol; 2023 Feb; 228(2):231.e1-231.e11. PubMed ID: 35985515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 as an independent risk factor for subclinical placental dysfunction.
    Jaiswal N; Puri M; Agarwal K; Singh S; Yadav R; Tiwary N; Tayal P; Vats B
    Eur J Obstet Gynecol Reprod Biol; 2021 Apr; 259():7-11. PubMed ID: 33556768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between fetal vascular malperfusion and gestational diabetes.
    Goto T; Sato Y; Kodama Y; Tomimori K; Sameshima H; Aman M; Maekawa K; Yamashita A; Asada Y
    J Obstet Gynaecol Res; 2022 Jan; 48(1):80-86. PubMed ID: 34729872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental vascular malperfusion lesions in fetal congenital heart disease.
    Leon RL; Sharma K; Mir IN; Herrera CL; Brown SL; Spong CY; Chalak LF
    Am J Obstet Gynecol; 2022 Oct; 227(4):620.e1-620.e8. PubMed ID: 35609643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.